Oncology

reducing people on team
Biotech

ArsenalBio halves staff amid reorganization efforts

The shift to a clinical focus does not impact the Bay Area biotech’s long-standing collaboration with BMS, an ArsenalBio spokesperson said.
Darren Incorvaia Sep 17, 2025 4:55pm
Servier

Servier hands Ideaya $210M upfront for ex-US rights to PKC asset

Sep 2, 2025 3:02pm
Monoclonal antibody orange red background 3d rendering

Allogene reports patient death tied to mAb in CAR-T pivotal trial

Aug 1, 2025 8:30am
world global globe ex-US country map regions

Roche's Flatiron triples cancer network across 3 countries

Jul 23, 2025 12:20pm
Roses chocolates suitor romance valentines day date love

Repare finds suitor for PKMYT1 inhibitor in partner Debiopharm

Jul 16, 2025 5:38am
Three blocks displaying from left to right a person a handshake and another person

Turnstone, once allied with AbbVie, accepts $8M Xoma buyout

Jun 27, 2025 9:00am
More News
Fierce Pharma

BioNTech to wind down cell therapy manufacturing in Maryland

Jun 18, 2025 10:23am

Actuate's pancreatic cancer drug boosts survival by 3 months

Jun 2, 2025 7:30am

AbbVie taps oncology research org for aid running diverse trials

May 28, 2025 11:25am

ASCO: Cullinan drug sees 35% ORR in pretreated NSCLC

May 22, 2025 5:00pm